The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular ...

This research team evaluated the effectiveness of switching patients to faricimab treatment by assessing their outcomes after ...

After winning a breakthrough therapy designation for its Hunter syndrome enzyme replacement therapy, Denali Therapeutics is ...

The search for new tuberculosis drug targets under traditional laboratory methods has historically proven to be arduous and ...